Randhawa Arshdeep K, Parikh Jash S, Kuk Jennifer L
School of Kinesiology and Health Science at York University, Toronto, Canada.
PLoS One. 2017 Sep 20;12(9):e0184089. doi: 10.1371/journal.pone.0184089. eCollection 2017.
Whether the increase in prescription medication use over time differs by age and obesity status is unclear.
National Health and Nutrition Examination Survey (NHANES) between 1988 and 2012 was analyzed (n = 57,543).
Increased medication use over time was seen in older individuals of all body mass index (BMI) classes, with the most prominent increase in those with obesity (p<0.001). For example, older men (≥65y) with obesity took 3.1 more medications between 1988 and 2012 versus 1.5 for normal weight older men. There were minimal differences in medication use over time in younger individuals. In men, the odds of taking antihypertensives, lipid-lowering medication, antidiabetics, and antidepressants increased with age, time and BMI wherein the association between age and medication use was magnified over time (age*time, p<0.05). In women, older women with overweight or obesity had a greater increase in the likelihood of antihypertensives and antidiabetics medication over time (BMI*time, p>0.05).
Older individuals of all BMI classes may be driving the increase in medication use over time. However, the rise in the likelihood of taking cardiometabolic medications over time was generally not different between those with or without obesity in men with some increases seen in older women. Further research may be required to assess accessibility and barriers to medication use among certain demographics.
随着时间推移,处方药使用量的增加是否因年龄和肥胖状况而异尚不清楚。
分析了1988年至2012年的国家健康与营养检查调查(NHANES)(n = 57,543)。
在所有体重指数(BMI)类别的老年人中,随着时间推移药物使用量均有所增加,肥胖者增加最为显著(p<0.001)。例如,1988年至2012年期间,肥胖的老年男性(≥65岁)多服用了3.1种药物,而正常体重的老年男性多服用了1.5种。年轻人随时间推移的药物使用差异极小。在男性中,服用抗高血压药、降脂药、抗糖尿病药和抗抑郁药的几率随年龄、时间和BMI增加,其中年龄与药物使用之间的关联随时间增强(年龄*时间,p<0.05)。在女性中,超重或肥胖的老年女性随着时间推移服用抗高血压药和抗糖尿病药的可能性增加更大(BMI*时间,p>0.05)。
所有BMI类别的老年人可能是随着时间推移药物使用增加的驱动因素。然而,男性中,无论有无肥胖,随着时间推移服用心脏代谢药物的可能性增加总体上没有差异,老年女性有一些增加。可能需要进一步研究来评估特定人群中药物使用的可及性和障碍。